Cervical cancer



Early diagnosis and personalized treatment of cervical cancer has shown a higher percentage of a cure.

Gynecologists, radiation oncologists and medical oncologists need to work together in order to offer the patient the best possibility of a cure.

Treatment is personalised in order to achieve the best results. Characteristics of the patient and tumor are analyzed by specialists at iTAcC.

Cervical cancer is the leading cause of death from gynecological cancer worldwide. Almost half of the cases are in women between the ages of 35 and 55.

Ahead of breast cancer, cervical cancer is the leading cause of female cancer mortality in many third world countries. In developed countries the incidence has decreased markedly in recent decades due to the campaigns of prevention and early diagnosis carried out in these countries. Approximately 2,100 cases are diagnosed annually in Spain.

Premalignant changes occur in the cells of the cervix even years before final development of cervical cancer. These premalignant changes can be referred to in various ways; dysplasia or cervical intraepithelial neoplasia (CIN). Early diagnosis is important in order to treat the disease in its early stages for achieving a higher cure rate.

85% to 90% of cervical tumors are squamous cell carcinomas while the remainder are mainly adenocarcinomas or adenosquamous carcinomas.